All nine children underwent testing for thrombophilia-related indicators, including antiphospholipid antibodies (aPL), protein C and protein S activity, antibodies to coagulation factors, and coagulation factor inhibitors. This evidence concerns the gene PROS1 and Rare hereditary thrombophilia.